Clinical Trials Browser

Bone Neoplasms, Neoplasms, Connective Tissue, Sarcoma, Osteosarcoma, Neoplasms, Connective and Soft Tissue

Hodgkin Disease

Hodgkin Disease

Triple Negative Breast Neoplasms

Sinonasal Tumors

Unresectable Sinonasal Tumors

Hepatocellular Carcinoma Resectable

Liver, Cancer of, Primary Resectable

Breast Neoplasms, Pancreatic Neoplasms

Breast Neoplasms, Neoplasm Metastasis

Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse

Ovarian Neoplasms

Plasmablastic Lymphoma, Burkitt Lymphoma, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse

Lymphoma, Large B-Cell, Diffuse

Carcinoma, Hepatocellular

Triple Negative Breast Neoplasms

Burkitt Lymphoma

Lymphoma, T-Cell, Peripheral

Multiple Myeloma

Lymphoma, Non-Hodgkin

Sarcoma, Neoplasms, Connective and Soft Tissue

The Neoadjuvant Therapy

Lymphoma, Large B-Cell, Diffuse

Hodgkin Disease

Breast Neoplasms

HER2-negative Breast Cancer

Stomach Neoplasms

Lymphoma, Large B-Cell, Diffuse

Hodgkin Disease

Multiple Myeloma

Hodgkin Disease

Breast Neoplasms

Carcinoma, Hepatocellular

Lymphoma, Large B-Cell, Diffuse

Lymphoma, T-Cell, Peripheral

Breast Neoplasms

Breast Cancer Organoids

Cholangiocarcinoma

Carcinoma, Hepatocellular

Lymphoma, Non-Hodgkin, Lymphohistiocytosis, Hemophagocytic

Neoplasms, Experimental

Osteosarcoma

Leukemia, Leukemia, T-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Leukemia, Leukemia, T-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Lymphoma, T-Cell, Peripheral

Multiple Myeloma

Clinical Trials

Neoadjuvant Combination of Doxorubicin, Cisplatin and Methotrexate in Patients Aged 24-40 Years With Primary Bone Tumors

BV-AVD-R Treatment Children Hodgkin's Lymphoma

PET-Directed Therapy With Pembrolizumab and Combination Chemotherapy in Treating Patients With Previously Untreated Classical Hodgkin Lymphoma

Effect of Platinum-based Versus Non-platinum-based Neoadjuvant Chemotherapy in Triple-negative Breast Cancer

Multidisciplinary Approach for Poor Prognosis Sinonasal Tumors in Operable Patients

Multidisciplinary Approach for Poor Prognosis Sinonasal Tumors in Inoperable Patients

Applicability of PDOX in Patients With Primary Liver Cancer: A Randomized Controlled Trial

Applicability of 3D-HDRA in Patients With Primary Liver Cancer: A Randomized Controlled Trial

Intestinal Microbiota Impact for Prognosis and Treatment Outcomes in Early Luminal Breast Cancer and Pancreatic Cancer Patients

Apatinib Mesylate Combined With Doxorubicin and Ifosfamide in Advanced Soft-tissue Sarcoma

TONIC

ZR2-CHOP

Study of 6b11-OCIK Injection Treatment in Patients With Recurrent Drug-resistant Ovarian Cancer

Combination Chemotherapy, Rituximab, and Ixazomib Citrate in Treating Patients With Non-Hodgkin Lymphoma

DLCL002 Protocol for Patients With High Risk Aggressive B-cell Lymphoma

SBRT or TACE for Advanced HCC

Neoadjuvant Camrelizumab Plus Chemotherapy in Triple Negative Breast Cancer

Treatment of Mature B-ALL and Burkitt Lymphoma (BL) in Adult Patients. BURKIMAB-14.

Brentuximab Vedotin in Combination With CHEP in Patient With PTCL

Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

Observation of the Efficacy of BAd Regimen in the Treatment of Relapsed and Refractory Multiple Myeloma

LYTPET

Camrelizumab Plus Doxorubicin for the First Line Treatment of Adcanced Soft Tissue Sarcoma

The Neoadjuvant Combined Hormone Therapy in Premenopausal Women With Locally Advanced ER+/HER2- Breast Cancer

Biomarker Guided Treatment in DLBCL

HD16

The Effect of Metformin on Breast Cancer Patients

Study of Tislelizumab Plus Chemotherapy vs Chemotherapy as Perioperative Treatment in Participants With HER2 Negative Breast Cancer

Pegliposomal Doxorubicin and 5-fluorouracil as Second Line Therapy for Metastatic Gastric Cancer

The Combination of Sintilimab and AI (Doxorubicin, ADM/Ifosfamide, IFO) for the First Line Treatment of Select Type of Metastatic/Unresectable Soft Tissue Sarcoma

DR-CHOP

Brentuximab Vedotin and Combination Chemotherapy in Treating Older Patients With Previously Untreated Stage II-IV Hodgkin Lymphoma

PDD vs PAD to Treat Initially Diagnosed MM

PEG-ASP+Gemoxd vs. PEG-ASP+CHOP as First-line Chemotherapy to Treatment NK/T-cell Lymphoma With Early Stage

(Optimist)

MBC1

Effectiveness of Drug Eluting TACE in Primary HCC

GVD±R Regimen for ASCT-eligible Patients With Refractory/Relapsed DLBCL

Efficacy and Safety of CDOP vs CHOP for Newly Diagnosed Peripheral T-cell Lymphoma

Cardiac Safety and Efficacy for Early-stage Breast Cancer Patients Treated With Pegylated Liposomal Doxorubicin（PLD)

Breast Cancer Treatment Based on Organ-like Culture

CHOLANGIO

LIFDOX

Trial of DA-EPOCH Regimen for NHL With HLH

Chidamide Combined With CHOPE Regimen for Peripheral T-cell Lymphoma Patients

Timing of Surgery in Nonmetastatic Osteosarcoma of the Pelvis and Sacrum

Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult T-LBL/ALL

Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult ETP-ALL

Efficacy and Safety of Decitabine Plus CHOP vs CHOP in Patients With Untreated Peripheral T-Cell Lymphoma

Modified Bortezomib-based Combination Therapy for Multiple Myeloma